Can an app predict epileptic seizures? new study aims to find out
NCT ID NCT07068919
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test whether a mobile app called EPIDAY can predict the daily risk of epileptic seizures in 50 adults with focal epilepsy. Participants will use the app to report symptoms and track seizures for three months. The goal is to see if machine learning can turn these reports into useful risk predictions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EPIDAY mobile application
- What this could lead to
- If successful, this could lead to a tool that helps people with epilepsy anticipate seizure risk and plan their day.
- What could go wrong
- This is a small, early-stage study with only 50 participants. The predictions may not be accurate enough for real-world use, and the app relies on self-reported symptoms, which can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Pitié-Salpêtrière, AP-HP
Paris, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a night of soft sounds sharpen the epileptic brain?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?